|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 25/06 | (2006.01) |
| A61K 31/225 | (2013.01) | ||
| A61K 31/12 | (2006.01) | ||
| A61P 25/06 | (2018.01) | ||
| A61K 31/21 | (2006.01) | ||
| A61K 31/231 | (2013.01) | ||
| A61K 31/231 | (2006.01) |
| (11) | Patento numeris | 3558458 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17884757.0 |
| Europos patento paraiškos padavimo data | 2017-11-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-10-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/063832 |
| Data | 2017-11-30 |
| (87) | Numeris | WO 2018/118369 |
| Data | 2018-06-28 |
| (30) | Numeris | Data | Šalis |
| 201615389828 | 2016-12-23 | US |
| (72) |
HASHIM, Sami , US
|
| (73) |
Neuroenergy Ventures, Inc. ,
Gellis Law Group
641 Lexington Avenue , 14th Floor, New York, NY 10022,
US
|
| (54) | GLYCERYL 3-HYDROXYBUTYRATES FOR MIGRAINE SYMPTOM MANAGEMENT |
| GLYCERYL 3-HYDROXYBUTYRATES FOR MIGRAINE SYMPTOM MANAGEMENT |